Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide effects on visceral organ function and lipid distribution in type 2 diabetes
ChiCTR1900023465Phase 4Recruiting
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoints: Abdominal fat quantification, Renal blood flow and 1 more. Started Jun 2019; status: recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900023465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023465.